Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data.

Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data.

Item
http://www.wikidata.org/entity/Q30559573
Nanotechnologies for noninvasive measurement of drug releaseNanoparticles for imaging and treating brain cancerA window on disease pathogenesis and potential therapeutic strategies: molecular imaging for arthritis.Histological study of the biodynamics of iron oxide nanoparticles with different diametersInfluence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivoBiological magnetic cellular spheroids as building blocks for tissue engineering.Morphologically virus-like fullerenol nanoparticles act as the dual-functional nanoadjuvant for HIV-1 vaccine.Safety assessment of gadobenate dimeglumine (MultiHance): extended clinical experience from phase I studies to post-marketing surveillance.Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents.Iron Oxide Nanoparticles: Innovative Tool in Cancer Diagnosis and Therapy.Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.In vitro and in vivo magnetic resonance tracking of Sinerem-labeled human umbilical mesenchymal stromal cell-derived Schwann cells.Superparamagnetic Nanoparticles and RNAi-Mediated Gene Silencing: Evolving Class of Cancer Diagnostics and Therapeutics
P2860

Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data.

Item
http://www.wikidata.org/entity/Q30559573
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Safety profile of ultrasmall s ...... phase II clinical trial data.
@ast
Safety profile of ultrasmall s ...... phase II clinical trial data.
@en
type
label
Safety profile of ultrasmall s ...... phase II clinical trial data.
@ast
Safety profile of ultrasmall s ...... phase II clinical trial data.
@en
prefLabel
Safety profile of ultrasmall s ...... phase II clinical trial data.
@ast
Safety profile of ultrasmall s ...... phase II clinical trial data.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Safety profile of ultrasmall s ...... phase II clinical trial data.
@en
P2093
P2860
P304
P31
P356
10.1002/(SICI)1522-2586(199902)9:2<291::AID-JMRI21>3.0.CO;2-#
P433
P478
P577
P698
P921